中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Stereotactic body radiation therapy favors long-term overall survival in patients with lung metastases: five-year experience of a single-institution

文献类型:期刊论文

作者Zhang Ye2; Xiao Jianping2; Zhang Hongzhi2; Yin Weibo2; Hu Yimin2; Song Yixin2; Zhang Ke2; Liao Zhongxing3; Li Yexiong2
刊名CHINESE MEDICAL JOURNAL
出版日期2011
卷号124
关键词RADIOTHERAPY TUMORS hypo-fractionated stereotactic body radiation therapy lung metastases prognosis
ISSN号0366-6999
其他题名Stereotactic body radiation therapy favors long-term overall survival in patients with lung metastases: five-year experience of a single-institution
英文摘要Background Metastatic lung cancer is one of the most common oncologic problems. This study aimed to evaluate the long-term clinical outcome of stereotactic body radiation therapy (SBRT) for metastatic lung tumors.
资助项目[Ministry of Science and Technology of China] ; [Capital Medical Development Scientific Research Fund of China]
语种英语
CSCD记录号CSCD:4401003
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/45653]  
专题中国科学院合肥物质科学研究院
作者单位1.Peking Union Med Coll, Beijing 100021, Peoples R China
2.中国科学院合肥物质科学研究院肿瘤医院
3.University Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
推荐引用方式
GB/T 7714
Zhang Ye,Xiao Jianping,Zhang Hongzhi,et al. Stereotactic body radiation therapy favors long-term overall survival in patients with lung metastases: five-year experience of a single-institution[J]. CHINESE MEDICAL JOURNAL,2011,124.
APA Zhang Ye.,Xiao Jianping.,Zhang Hongzhi.,Yin Weibo.,Hu Yimin.,...&Li Yexiong.(2011).Stereotactic body radiation therapy favors long-term overall survival in patients with lung metastases: five-year experience of a single-institution.CHINESE MEDICAL JOURNAL,124.
MLA Zhang Ye,et al."Stereotactic body radiation therapy favors long-term overall survival in patients with lung metastases: five-year experience of a single-institution".CHINESE MEDICAL JOURNAL 124(2011).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。